The State of Myeloproliferative Neoplasms (MPNs) - Episode 6
Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.
Related Content:
Ceralasertib-Imfinzi Misses Survival End Point in Lung Cancer Trial
Cognitive Health Gains Focus in Kidney Cancer Survivorship
One More Christmas: How Cancer Changed How I Experience the Holidays
Trodelvy Shows Fewer Side Effects Than Chemotherapy in Some With TNBC